Dehydroepiandrosterone (DHEA) is synthesized in the adrenals and the brain. Additionally, DHEA is produced at high concentrations in the human embryo enhancing neuronal development. Its production rate and levels in serum, brain and adrenals decrease gradually with advancing age. This decline was associated to age-related neuronal dysfunction and degeneration, suggesting a neuroprotective effect of endogenous DHEA against noxious agents. This hypothesis is substantiated by experimental findings showing that DHEA protect neural crest derived cells against serum deprivation-induced apoptosis with EC50 1.8 nM. This potent antiapoptotic effect of DHEA is mediated by G-protein coupled specific membrane binding sites, the subsequent activation of prosurvival kinases Src and PKC and transcription factors CREB and NF-κB, upstream effectors of the antiapoptotic Bcl-2 proteins. These findings suggest that DHEA may act as an endogenous neuroprotective factor, during development and in adulthood. The decline of DHEA levels during ageing may leave the brain unprotected against neurotoxic challenges. The DHEA specific membrane binding sites conferring neuroprotection offer a new target for developing synthetic DHEA analogs with antiapoptotic and neuroprotective properties, deprived of endocrine toxicity.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Orentreich N, Brind JL, Rizer RL, et al. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 1984; 59:551–555.
Be’langer A, Candas B, Dupont A, et al. Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year old men. J Clin Endocrinol Metab 1994; 79:1086–1090.
Wolkowitz OM, Epel, ES, Reus VI. Stress hormone-related psychopathology: pathophysiological and treatment implications. World J Biol Psychiatry 2001; 2:115–143.
Straub RH, Lehle K, Herfarth H, Weber, et al. Dehydroepiandrosterone in relation to other adrenal hormones during an acute inflammatory stressful disease state compared with chronic inflammatory disease: role of interleukin-6 and tumour necrosis factor. Eur J Endocrinol 2002; 146:365–374.
Sapolsky RM. Stress, the aging brain and the mechanism of neuron death. Cambridge, MA: MIT, 1992.
Seals DR, Esler M. Human ageing and the sympathoadrenal system. J Physiol 2000; 528:407–417.
Esler M, Lambert G, Kaye D, et al. Influence of ageing on the sympathetic nervous system and adrenal medulla at rest and during stress. Biogerontology 2002; 3:45–49.
Bastianetto S, Ramassamy C, Poirier, et al. Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage. Brain Res Mol Brain Res 1999; 66:35–41.
Cardounel A, Regelson W, Kalimi M. Dehydroepiandrosterone protects hippocampal neurons against neurotoxin-induced cell death: mechanism of action. Proc Soc Exp Biol Med 1999; 22:145–149.
Lapchak PA, Chapman DF, Nunez SY, et al. Dehydroepiandrosterone sulfate is neuroprotective in a reversible spinal cord ischemia model: possible involvement of GABA(A) receptors. Stroke 2000; 31:1953–1956.
Kimonides VG, Khatibi NH, Svendsen CN, et al. Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. Proc Natl Acad Sci USA 1998; 95:1852–1857.
Weill-Engerer S, David JP, Sazdovitch V, et al. Neurosteroid quantification in human brain regions: comparison between Alzheimer’s and nondemented patients. J Clin Endocrinol Metab 2002; 87:5138–5143.
Schumacher M, Weill-Engerer S, Liere P, et al. Steroid hormones and neurosteroids in normal and pathological aging of the nervous system. Prog Neurobiol 2003; 71:3–29.
Belanger N, Gregoire L, Bedard P, et al. Estradiol and dehydroepiandrosterone potentiate levodopa-induced locomotor activity in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine monkeys. Endocrine 2003; 1:97–101.
Belanger N, Gregoire L, Bedard PJ, et al. DHEA improves symptomatic treatment of moderately and severely impaired MPTP monkeys. Neurobiol Aging 2006; 11:1684–1693.
Charalampopoulos I, Tsatsanis C, Dermitzaki E, et al. Dehydroepiandrosterone and allopregnanolone protect sympathoadrenal cells against apoptosis, via Bcl-2 antiapoptotic proteins. Proc Natl Acad Sci USA 2004; 101:8209–8214.
Riccio A, Ahn S, Davenport CM, et al. Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons. Science 1999; 286:2358–2361.
Tamatani M, Che YH, Matsuzaki H, et al. Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons. J Biol Chem 1999; 274:8531–8538.
Ruvolo P, Deng X, Carr B, et al. A functional role for mitochondrial protein kinase Calpha in Bcl2 phosphorylation and suppression of apoptosis. J Biol Chem 1998; 273:25436–25442.
Charalampopoulos I, Alexaki VI, Lazaridis I, et al. G protein-associated, specific membrane binding sites mediate the neuroprotective effect of Dehydroepiandrosterone. FASEB J 2006; 20:577–579.
Wooten M, Seibenhener ML, Neidich K, et al. Mapping of atypical protein kinase C within the nerve growth factor signaling cascade: relationship to differentiation and survival of PC12 cells. Mol Cell Biol 2000; 20:4494–4504.
Swaab DF, Bao AM, Lucassen PJ. The stress system in the human brain in depression and neurodegeneration. Ageing Res Rev 2005; 2:141–194.
Sapolsky RM. Glucocorticoid toxicity in the hippocampus: reversal by supplementation with brain fuels. J Neurosci 1986; 6:2240–2244.
Sapolsky RM, Krey LC, McEwen BC. The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocrine Revs 1986; 7:284–301.
Marder K, Tang MX, Mejia H, et al. Risk of Parkinson’s disease among first-degree relatives: a community-based study. Neurology 1996; 47:155–160.
Yang SH, Perez E, Cutright J, et al. Testosterone increases neurotoxicity of glutamate in vitro and ischemia-reperfusion injury in an animal model. J Appl Physiol 2002; 1:195–201.
Swaab DF, Raadsheer FC, Endert E, et al. Increased cortisol levels in aging and Alzheimer’s disease in postmortem cerebrospinal fluid. J Neuroendocrinol 1994; 6:681–687.
Umegaki H, Ikari H, Nakahata H, et al. Plasma cortisol levels in elderly female subjects with Alzheimer’s disease: a cross-sectional and longitudinal study. Brain Res 2000; 881:241–243.
Mattson M. Apoptosis in neurodegenerative disorders. Nature Rev Mol Cell Biol 2000; 1:120–129.
Kratnic S, Mechawar N, Reix S, et al. Molecular basis of programmed cell death involved in neurodegeneration. Trends Neurosci 2006; 28:670–676.
Forman MS, Trojanowski J, Lee V. Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nature Med 2004; 10:1055–1063.
Charalampopoulos I, Dermitzaki E, Vardouli L, et al. Dehydroepiandrosterone and allopregnanolone directly stimulate catecholamine production via induction of tyrosine hydroxylase and secretion by affecting actin polymerization. Endocrinology 2005; 146:3309–3318.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science + Business Media, B.V
About this chapter
Cite this chapter
Charalampopoulos, I., Tsatsanis, C., Margioris, A.N., Castanas, E., Gravanis, A. (2008). Dehydroepiandrosterone, as Endogenous Inhibitor of Neuronal Cell Apoptosis: Potential Therapeutic Implications in Neurodegenerative Diseases. In: Ritsner, M.S., Weizman, A. (eds) Neuroactive Steroids in Brain Function, Behavior and Neuropsychiatric Disorders. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-6854-6_11
Download citation
DOI: https://doi.org/10.1007/978-1-4020-6854-6_11
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-6853-9
Online ISBN: 978-1-4020-6854-6
eBook Packages: MedicineMedicine (R0)